Current & Critical - Stephen Van Deventer, Cannabis & BioTech - An Insider's POV
In this episode, you\u2019ll learn about the pharmaceutical application of cannabis. With the legalization of cannabis in Canada, R&D and commercialization in medical cannabis are poised to reap rewards. Stephen Van Deventer, Chairman and CEO of Astern Cannabis Inc. and PreveCeutical Medical Inc., discusses how they fingerprint cannabis cannabinoids, terpenes, and flavonoids to determine their medical applications. Stephen discusses PreveCeutical\u2019s expansion into Australia, the Canadian government\u2019s reaction to their findings, and how his company is approaching commercialization in a different way, as well as how investors are responding.